Identification of residues important both for primary receptor binding and specificity in fibroblast growth factor-7
- PMID: 10950949
- DOI: 10.1074/jbc.M003293200
Identification of residues important both for primary receptor binding and specificity in fibroblast growth factor-7
Abstract
Fibroblast growth factors (FGFs) mediate a multitude of physiological and pathological processes by activating a family of tyrosine kinase receptors (FGFRs). Each FGFR binds to a unique subset of FGFs and ligand binding specificity is essential in regulating FGF activity. FGF-7 recognizes one FGFR isoform known as the FGFR2 IIIb isoform or keratinocyte growth factor receptor (KGFR), whereas FGF-2 binds well to FGFR1, FGFR2, and FGFR4 but interacts poorly with KGFR. Previously, mutations in FGF-2 identified a set of residues that are important for high affinity receptor binding, known as the primary receptor-binding site. FGF-7 contains this primary site as well as a region that restricts interaction with FGFR1. The sequences that confer on FGF-7 its specific binding to KGFR have not been identified. By utilizing domain swapping and site-directed mutagenesis we have found that the loop connecting the beta4-beta5 strands of FGF-7 contributes to high affinity receptor binding and is critical for KGFR recognition. Replacement of this loop with the homologous loop from FGF-2 dramatically reduced both the affinity of FGF-7 for KGFR and its biological potency but did not result in the ability to bind FGFR1. Point mutations in residues comprising this loop of FGF-7 reduced both binding affinity and biological potency. The reciprocal loop replacement mutant (FGF2-L4/7) retained FGF-2 like affinity for FGFR1 and for KGFR. Our results show that topologically similar regions in these two FGFs have different roles in regulating receptor binding specificity and suggest that specificity may require the concerted action of distinct regions of an FGF.
Similar articles
-
Mutations uncouple human fibroblast growth factor (FGF)-7 biological activity and receptor binding and support broad specificity in the secondary receptor binding site of FGFs.J Biol Chem. 1999 Dec 3;274(49):35016-22. doi: 10.1074/jbc.274.49.35016. J Biol Chem. 1999. PMID: 10574979
-
Chimeric molecules between keratinocyte growth factor and basic fibroblast growth factor define domains that confer receptor binding specificities.J Biol Chem. 1995 Dec 15;270(50):29813-8. doi: 10.1074/jbc.270.50.29813. J Biol Chem. 1995. PMID: 8530375
-
Molecular modeling based mutagenesis defines ligand binding and specificity determining regions of fibroblast growth factor receptors.Biochemistry. 1995 Aug 22;34(33):10325-33. doi: 10.1021/bi00033a002. Biochemistry. 1995. PMID: 7544612
-
Heparan sulfate fibroblast growth factor receptor complex: structure-function relationships.Mol Reprod Dev. 1994 Sep;39(1):69-81; discusison 81-2. doi: 10.1002/mrd.1080390112. Mol Reprod Dev. 1994. PMID: 7999363 Review.
-
Keratinocyte growth factor as a cytokine that mediates mesenchymal-epithelial interaction.EXS. 1995;74:191-214. doi: 10.1007/978-3-0348-9070-0_10. EXS. 1995. PMID: 8527895 Review.
Cited by
-
Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents.J Clin Invest. 2009 Mar;119(3):512-23. doi: 10.1172/JCI35070. Epub 2009 Feb 9. J Clin Invest. 2009. PMID: 19197140 Free PMC article.
-
Cheiradone: a vascular endothelial cell growth factor receptor antagonist.BMC Cell Biol. 2008 Jan 29;9:7. doi: 10.1186/1471-2121-9-7. BMC Cell Biol. 2008. PMID: 18230134 Free PMC article.
-
Sustained activation of the HER1-ERK1/2-RSK signaling pathway controls myoepithelial cell fate in human mammary tissue.Genes Dev. 2011 Aug 1;25(15):1641-53. doi: 10.1101/gad.2025611. Genes Dev. 2011. PMID: 21828273 Free PMC article.
-
Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors.Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2266-71. doi: 10.1073/pnas.0436500100. Epub 2003 Feb 18. Proc Natl Acad Sci U S A. 2003. PMID: 12591959 Free PMC article.
-
Rational Design and Production of Bioactive Analogs of Recombinant Human Keratinocyte Growth Factor (rhKGF) with Reduced Aggregation Propensity.Protein J. 2023 Feb;42(1):37-54. doi: 10.1007/s10930-023-10089-6. Epub 2023 Jan 23. Protein J. 2023. PMID: 36683078
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous